SCYL1
Basic information
Region (hg38): 11:65525077-65538704
Previous symbols: [ "NTKL" ]
Links
Phenotypes
GenCC
Source:
- acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome (Supportive), mode of inheritance: AR
- acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome (Moderate), mode of inheritance: AR
- acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome (Strong), mode of inheritance: AR
- acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Spinocerebellar ataxia, autosomal recessive 21 | AR | Gastrointestinal | Individuals have been described with childhood-onset acute liver failure, and awareness may allow surveillance and prompt management | Gastrointestinal; Neurologic | 26581903 |
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn_genetic_diseases (128 variants)
- not_provided (99 variants)
- Acute_infantile_liver_failure-cerebellar_ataxia-peripheral_sensory_motor_neuropathy_syndrome (29 variants)
- SCYL1-related_disorder (19 variants)
- not_specified (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SCYL1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000020680.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 40 | 46 | ||||
| missense | 125 | 15 | 146 | |||
| nonsense | 9 | |||||
| start loss | 1 | 1 | 2 | |||
| frameshift | 15 | |||||
| splice donor/acceptor (+/-2bp) | 5 | |||||
| Total | 20 | 15 | 126 | 55 | 7 |
Highest pathogenic variant AF is 0.00003533832
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| SCYL1 | protein_coding | protein_coding | ENST00000270176 | 18 | 13628 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 2.52e-8 | 1.00 | 124778 | 0 | 51 | 124829 | 0.000204 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.33 | 405 | 488 | 0.830 | 0.0000299 | 5219 |
| Missense in Polyphen | 98 | 127.28 | 0.76996 | 1340 | ||
| Synonymous | -0.0597 | 208 | 207 | 1.01 | 0.0000137 | 1624 |
| Loss of Function | 3.25 | 20 | 43.0 | 0.466 | 0.00000233 | 448 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000345 | 0.000345 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000223 | 0.000223 |
| Finnish | 0.000447 | 0.000417 |
| European (Non-Finnish) | 0.000214 | 0.000212 |
| Middle Eastern | 0.000223 | 0.000223 |
| South Asian | 0.000164 | 0.000163 |
| Other | 0.000165 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Regulates COPI-mediated retrograde protein traffic at the interface between the Golgi apparatus and the endoplasmic reticulum (PubMed:18556652). Involved in the maintenance of the Golgi apparatus morphology (PubMed:26581903). Has no detectable kinase activity in vitro (PubMed:18556652). {ECO:0000269|PubMed:18556652, ECO:0000269|PubMed:26581903}.;
- Disease
- DISEASE: Spinocerebellar ataxia, autosomal recessive, 21 (SCAR21) [MIM:616719]: A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR21 is characterized by cerebellar atrophy and ataxia with onset in early childhood. Patients also manifest recurrent episodes of liver failure, hepatic fibrosis and a peripheral neuropathy. {ECO:0000269|PubMed:26581903}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- miR-targeted genes in epithelium - TarBase;miR-targeted genes in leukocytes - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase
(Consensus)
Recessive Scores
- pRec
- 0.147
Intolerance Scores
- loftool
- 0.678
- rvis_EVS
- 0.47
- rvis_percentile_EVS
- 78.83
Haploinsufficiency Scores
- pHI
- 0.270
- hipred
- Y
- hipred_score
- 0.637
- ghis
- 0.524
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.760
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Scyl1
- Phenotype
- muscle phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; growth/size/body region phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;peptidyl-tyrosine phosphorylation
- Cellular component
- nucleus;cytoplasm;endoplasmic reticulum-Golgi intermediate compartment;Golgi apparatus;cis-Golgi network;microtubule organizing center;cytosol;membrane;COPI vesicle coat
- Molecular function
- DNA binding;protein tyrosine kinase activity;ATP binding;cadherin binding